[RobinP]

Hi,

I find the finnish study very interesting, particularly since the media has boosted of the study, noting less Herceptin, 9weeks compared to one year, with less cardiac side effects for those who test positie for her2.However, I would love to see this study reproduced on a larger scale to see if the same findings would results. Additionally, I might add that in the Finnish study, many were on Taxol with herceptin. And it appears that clinically Taxol is more effective than other chemotherapy agents against her2 so we must attribute some of the sucess of the finnish study to Taxol as well.

PS To view the Finnish study, click on main message board, SABC, then on adjuvant herceptin, shortened treatment.